Molecular Diagnosis

, Volume 6, Issue 4, pp 347–349 | Cite as

Clinical News Update

  • Richard D. Press
Clinical News Update


Ferritin Iron Overload Hemochromatosis NOD2 Mutation Pathology Community 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Njajou OT, Vaessen N, Joosse M, et al.: A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213–214PubMedCrossRefGoogle Scholar
  2. 2.
    Montosi G, Donovan A, Totaro A, et al.: Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619–623PubMedGoogle Scholar
  3. 3.
    Kato J, Fujikawa K, Kanda M, et al.: A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191–197PubMedCrossRefGoogle Scholar
  4. 4.
    Hugot JP, Chamaillard M, Zouali H, et al.: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599–603PubMedCrossRefGoogle Scholar
  5. 5.
    Ogura Y, Bonen DK, Inohara N, et al.: A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001;411:603–606PubMedCrossRefGoogle Scholar
  6. 6.
    Hampe J, Cuthbert A, Croucher PJ, et al.: Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 2001;357:1925–1928PubMedCrossRefGoogle Scholar

Copyright information

© Churchill Livingstone® 2001

Authors and Affiliations

  • Richard D. Press
    • 1
  1. 1.Oregon Health Sciences UniversityPortlandUSA

Personalised recommendations